Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus
Objective: To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 × 0.2 mg/kg at 12‐h intervals) for symptomatic patent ductus arteriosus. Patients and Methods: We performed a retrospective multi‐centre double cohort study in preterm...
Saved in:
| Published in | Acta Paediatrica Vol. 98; no. 5; pp. 797 - 803 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.05.2009
Blackwell |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Objective: To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 × 0.2 mg/kg at 12‐h intervals) for symptomatic patent ductus arteriosus.
Patients and Methods: We performed a retrospective multi‐centre double cohort study in preterm infants <32 weeks of gestational age. Thirty‐two infants treated with furosemide (1 mg/kg i.v.) before each indomethacin dose (furosemide group) were matched with 32 infants with indomethacin treatment alone (control‐group). Renal effects (urine output, weight gain, serum creatinine, sodium concentration) were registered.
Results: The study groups were comparable for gestational age, birth weight and day of therapy. Pretreatment differences were observed for urine output, weight and serum sodium. However, no differences were noticed in day‐to‐day urine output change or weight gain between the groups. A significant increase in serum creatinine concentration (50% vs. control, 18%; p < 0.05) and a concomitant significant decrease in serum sodium (–9 vs. control, –3 mmoL/L; p < 0.05) in the furosemide group was observed 72–96 h after starting therapy.
Conclusion: Furosemide before each indomethacin dose resulted in a significant increase in serum creatinine and hyponatremia, without increasing urine output. |
|---|---|
| AbstractList | Objective: To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 × 0.2 mg/kg at 12‐h intervals) for symptomatic patent ductus arteriosus.
Patients and Methods: We performed a retrospective multi‐centre double cohort study in preterm infants <32 weeks of gestational age. Thirty‐two infants treated with furosemide (1 mg/kg i.v.) before each indomethacin dose (furosemide group) were matched with 32 infants with indomethacin treatment alone (control‐group). Renal effects (urine output, weight gain, serum creatinine, sodium concentration) were registered.
Results: The study groups were comparable for gestational age, birth weight and day of therapy. Pretreatment differences were observed for urine output, weight and serum sodium. However, no differences were noticed in day‐to‐day urine output change or weight gain between the groups. A significant increase in serum creatinine concentration (50% vs. control, 18%; p < 0.05) and a concomitant significant decrease in serum sodium (–9 vs. control, –3 mmoL/L; p < 0.05) in the furosemide group was observed 72–96 h after starting therapy.
Conclusion: Furosemide before each indomethacin dose resulted in a significant increase in serum creatinine and hyponatremia, without increasing urine output. Abstract Objective: To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 × 0.2 mg/kg at 12‐h intervals) for symptomatic patent ductus arteriosus. Patients and Methods: We performed a retrospective multi‐centre double cohort study in preterm infants <32 weeks of gestational age. Thirty‐two infants treated with furosemide (1 mg/kg i.v.) before each indomethacin dose (furosemide group) were matched with 32 infants with indomethacin treatment alone (control‐group). Renal effects (urine output, weight gain, serum creatinine, sodium concentration) were registered. Results: The study groups were comparable for gestational age, birth weight and day of therapy. Pretreatment differences were observed for urine output, weight and serum sodium. However, no differences were noticed in day‐to‐day urine output change or weight gain between the groups. A significant increase in serum creatinine concentration (50% vs. control, 18%; p < 0.05) and a concomitant significant decrease in serum sodium (–9 vs. control, –3 mmoL/L; p < 0.05) in the furosemide group was observed 72–96 h after starting therapy. Conclusion: Furosemide before each indomethacin dose resulted in a significant increase in serum creatinine and hyponatremia, without increasing urine output. To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 x 0.2 mg/kg at 12-h intervals) for symptomatic patent ductus arteriosus. We performed a retrospective multi-centre double cohort study in preterm infants <32 weeks of gestational age. Thirty-two infants treated with furosemide (1 mg/kg i.v.) before each indomethacin dose (furosemide group) were matched with 32 infants with indomethacin treatment alone (control-group). Renal effects (urine output, weight gain, serum creatinine, sodium concentration) were registered. The study groups were comparable for gestational age, birth weight and day of therapy. Pretreatment differences were observed for urine output, weight and serum sodium. However, no differences were noticed in day-to-day urine output change or weight gain between the groups. A significant increase in serum creatinine concentration (50% vs. control, 18%; p < 0.05) and a concomitant significant decrease in serum sodium (-9 vs. control, -3 mmoL/L; p < 0.05) in the furosemide group was observed 72-96 h after starting therapy. Furosemide before each indomethacin dose resulted in a significant increase in serum creatinine and hyponatremia, without increasing urine output. |
| Author | Van Overmeire, Bart Tanke, Ronald B. Oetomo, Sidarto Bambang Andriessen, Peter Niemarkt, Hendrik Struis, Nicole C. |
| Author_xml | – sequence: 1 givenname: Peter surname: Andriessen fullname: Andriessen, Peter organization: Department of Neonatology, Máxima Medical Centre, Veldhoven, The Netherlands – sequence: 2 givenname: Nicole C. surname: Struis fullname: Struis, Nicole C. organization: Department of Neonatology, Máxima Medical Centre, Veldhoven, The Netherlands – sequence: 3 givenname: Hendrik surname: Niemarkt fullname: Niemarkt, Hendrik organization: Department of Neonatology, Máxima Medical Centre, Veldhoven, The Netherlands – sequence: 4 givenname: Sidarto Bambang surname: Oetomo fullname: Oetomo, Sidarto Bambang organization: Department of Neonatology, Máxima Medical Centre, Veldhoven, The Netherlands – sequence: 5 givenname: Ronald B. surname: Tanke fullname: Tanke, Ronald B. organization: Department of Paediatric Cardiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands – sequence: 6 givenname: Bart surname: Van Overmeire fullname: Van Overmeire, Bart organization: Department of Paediatrics, division of Neonatology, Antwerp University Hospital, Edegem, Belgium |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21458824$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19187396$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkMlOwzAQhi1URBd4BZQLxwRvWXzgUFW0RSqlhyKOlhM7akqzyHbU9u1xSFWu-OKR5_tGnn8MBlVdKQA8BAPkzvM-QFGIfIxxHGAIWQARxjQ43YDRtTEAI5hA4oc4JEMwNmYPISaMRndgiBhKYsKiEdjOW10bVRZSeUXlNVpZpUtX5qKyxrNaCaukdyzszj3KulR2JzJH5rX2GterrCfbzLbGE9qpRW1acw9uc3Ew6uFyT8Dn_HU7W_qrj8XbbLryM0pC6pNURilWitE0Z1QKhgWMlCDUrZSzCIkspgwzFuOYYinShEoSuXVQmGQUxZBMQNLPzdwORqucN7oohT5zBHkXFN_zLg_e5cG7oPhvUPzk1Mdebdq0VPJPvCTjgKcLIEwmDrkWVVaYK4cRDZMEU8e99NyxOKjzvz_Ap5tpVznf7_3CWHW6-kJ_8ygmcci_1gvOFhu2Xr6vOSI_OwGU_Q |
| CitedBy_id | crossref_primary_10_1038_s41372_022_01450_1 crossref_primary_10_14734_kjp_2013_24_2_72 crossref_primary_10_1542_neo_11_9_e495 crossref_primary_10_1053_j_semperi_2011_09_022 crossref_primary_10_1016_j_clp_2011_12_007 crossref_primary_10_1038_jp_2012_31 crossref_primary_10_1590_S1807_59322011001200022 crossref_primary_10_7599_hmr_2009_29_4_323 crossref_primary_10_1017_S104795111700052X crossref_primary_10_1111_j_1365_2044_2009_06228_x crossref_primary_10_2165_11596620_000000000_00000 crossref_primary_10_1007_s40272_013_0031_7 crossref_primary_10_1053_j_jvca_2020_10_014 crossref_primary_10_1111_j_1651_2227_2012_02699_x crossref_primary_10_1016_S8756_5005_09_79142_5 |
| Cites_doi | 10.1891/0730-0832.26.3.187 10.1007/BF00441143 10.1080/14767050600922610 10.1016/S0009-9236(97)90066-7 10.1016/S0022-3476(05)83391-8 10.1111/j.1651-2227.2004.tb00712.x 10.1016/j.siny.2004.10.003 10.1161/01.RES.53.5.630 10.1056/NEJM198303313081303 10.1542/peds.68.1.99 10.1007/s00467-005-2022-6 10.1007/BF01063855 10.1007/s00467-006-0224-1 10.1097/00003246-200202000-00013 10.1056/NEJM200009073431001 10.1007/s00467-003-1402-z 10.1159/000088046 10.1053/siny.2000.0036 10.1159/000241622 10.1007/s00431-002-0915-y 10.1016/S0022-3476(78)81182-2 10.1111/j.1651-2227.1996.tb13942.x 10.1007/s00246-006-0093-1 10.1055/s-2008-1040750 10.1016/S0022-3476(82)80079-6 |
| ContentType | Journal Article |
| Copyright | 2009 The Author(s)/Journal Compilation ©2009 Foundation Acta Pædiatrica 2009 INIST-CNRS |
| Copyright_xml | – notice: 2009 The Author(s)/Journal Compilation ©2009 Foundation Acta Pædiatrica – notice: 2009 INIST-CNRS |
| DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION |
| DOI | 10.1111/j.1651-2227.2009.01224.x |
| DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
| DatabaseTitleList | CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1651-2227 |
| EndPage | 803 |
| ExternalDocumentID | 10_1111_j_1651_2227_2009_01224_x 19187396 21458824 APA1224 ark_67375_WNG_9GP9NHMN_1 |
| Genre | article Multicenter Study Journal Article |
| GroupedDBID | .55 .GA .GJ 1OC 3O- 51W 51X 52N 52O 52P 52R 52T 52W 52X 53G 5GY 5HH 5LA 5RE 66C 7PT 930 A01 A03 AAWTL ABDBF ABPTK ACGFS AEQTP AI. ALMA_UNASSIGNED_HOLDINGS BSCLL BY8 EAD EAP EAS EBC EBD EBX EMB EMK EMOBN EPT ESX F5P LP6 LP7 N9D P4B P4D Q~Q SV3 TUS VH1 WQJ WRC WXI X7M ZA5 ZGI .3N .Y3 05W 08R 0R~ 10A 1OB 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52S 52U 52V 5VS 702 8-0 8-1 8-3 8-4 8-5 8UM AAESR AAEVG AAHHS AANLZ AAONW AAQQT AASGY AAUGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIVO ABLJU ABPVW ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGEJ ACGOF ACMXC ACPOU ACPRK ACSCC ACSMX ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXPE ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHEFC AHMBA AIACR AIURR AIWBW AJBDE AJWEG ALAGY ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBS EJD EX3 F00 F01 F04 FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HZ~ IQODW IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OVD P2W P2X P2Z PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WUP WVDHM WXSBR XG1 ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION |
| ID | FETCH-LOGICAL-c4354-3bd6b2ee94bf94da92a06ea34200f961ac74929972742dab84d36525158c41703 |
| IEDL.DBID | DR2 |
| ISSN | 0803-5253 |
| IngestDate | Fri Aug 23 02:01:09 EDT 2024 Sat Sep 28 07:51:28 EDT 2024 Sun Oct 22 16:07:04 EDT 2023 Sat Aug 24 00:51:20 EDT 2024 Wed Jan 17 05:02:01 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Human Premature Prostaglandin-endoperoxide synthase Pediatrics Renal function Patent ductus arteriosus Enzyme Indometacin Enzyme inhibitor Persistence of ductus arteriosus Infant Furosemide Tocolytic Non steroidal antiinflammatory agent Diuretic Newborn diseases Treatment Prematurity Sulfonamides Indoleacetic acid derivatives Anthranilic acid derivatives Antihypertensive agent Oxidoreductases Indomethacin |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4354-3bd6b2ee94bf94da92a06ea34200f961ac74929972742dab84d36525158c41703 |
| Notes | ArticleID:APA1224 ark:/67375/WNG-9GP9NHMN-1 istex:8F57D1F920AE2BF59059F5FFFD819221D7A16596 |
| PMID | 19187396 |
| PageCount | 7 |
| ParticipantIDs | crossref_primary_10_1111_j_1651_2227_2009_01224_x pubmed_primary_19187396 pascalfrancis_primary_21458824 wiley_primary_10_1111_j_1651_2227_2009_01224_x_APA1224 istex_primary_ark_67375_WNG_9GP9NHMN_1 |
| PublicationCentury | 2000 |
| PublicationDate | May 2009 |
| PublicationDateYYYYMMDD | 2009-05-01 |
| PublicationDate_xml | – month: 05 year: 2009 text: May 2009 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Norway |
| PublicationTitle | Acta Paediatrica |
| PublicationTitleAlternate | Acta Paediatr |
| PublicationYear | 2009 |
| Publisher | Blackwell Publishing Ltd Blackwell |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
| References | Reyes JL, Aldana I, Barbier O, Parrales AA, Melendez E. Indomethacin decreases furosemide-induced natriuresis and diuresis on the neonatal kidney. Pediatr Nephrol 2006; 21: 1690-7. Johnston GD, Hiatt WR, Nies AS, Payne NA, Murphy RC, Gerber JG. Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res 1983; 53: 630-5. Nies AS, Fadul S, Gal J, Gerber JG. Indomethacin-furosemide interaction: the importance of renal blood flow. Adv Prostaglandin Thromboxane Leukot Res 1983; 11: 529-33. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001; 6: 63-73. Zanardo V, Vedovato S, Lago P, Piva D, Faggian D, Chiozza L. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus. Fetal Diagn Ther 2005; 20: 534-9. Romagnoli C, Zecca E, Papacci P, De Carolis MP, Giannini R, Gallini F, et al. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. Clin Pharmacol Ther 1997; 62: 181-6. Vargas-Origel A, Cruz-Anguiano V, Lopez-Montano E. Indomethacin and furosemide in closure of ductus arteriosus. Bol Med Hosp Infant Mex 1986; 43: 482-8. Van Den Anker JN. Pharmacokinetics and renal function in preterm infants. Acta Paediatr 1996; 85: 1393-9. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002; 161: 202-7. Akima S, Kent A, Reynolds GJ, Gallagher M, Falk MC. Indomethacin and renal impairment in neonates. Pediatr Nephrol 2004; 19: 490-3. Leonhardt A, Strehl R, Barth H, Seyberth HW. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. Acta Paediatr 2004; 93: 233-40. Van Overmeire B, Smets K, Lecoutere D, Van de BH, Weyler J, Degroote K, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674-81. Yeh TF, Wilks A, Singh J, Betkerur M, Lilien L, Pildes RS. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. J Pediatr 1982; 101: 433-7. Chennavasin P, Seiwell R, Brater DC. Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man. J Pharmacol Exp Ther 1980; 215: 77-81. Srinivasjois RM, Nathan EA, Doherty DA, Patole SK. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates-is postnatal age at start of treatment important? J Matern Fetal Neonatal Med 2006; 19: 793-9. Barrington KJ, Fox M. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus. Am J Perinatol 1994; 11: 220-2. Friedman Z, Demers LM, Marks KH, Uhrmann S, Maisels MJ. Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants. J Pediatr 1978; 93: 512-15. Van Bel F, Guit GL, Schipper J, Van De BM, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991; 118: 621-6. Mrongovius R, Imbeck H, Wille L, Muller H, Seyberth HW. Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants. Eur J Pediatr 1982; 138: 151-3. Shaffer CL, Gal P, Ransom JL, Carlos RQ, Smith MS, Davey AM, et al. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Crit Care Med 2002; 30: 343-8. Kover G, Tost H. The effect of indomethacin on kidney function: indomethacin and furosemide antagonism. Pflugers Arch 1977; 372: 215-20. Amin SB, Handley C, Carter-Pokras O. Indomethacin use for the management of patent ductus arteriosus in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States. Pediatr Cardiol 2007; 28: 193-200. Brion LP, Campbell DE. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants. Cochrane Database Syst Rev 2001: CD001148. Katayama S, Attallah AA, Stahl RA, Bloch DL, Lee JB. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2. Am J Physiol 1984; 247: F555-61. Tulassay T, Machay T, Kiszel J, Varga J. Effects of continuous positive airway pressure on renal function in prematures. Biol Neonate 1983; 43: 152-7. Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981; 68: 99-102. Zanardo V, Vedovato S, Lago P, Trevisanuto D, Favaro F, Faggian D, et al. Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus. Pediatr Nephrol 2005; 20: 1552-6. Green TP, Thompson TR, Johnson DE, Lock JE. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med 1983; 308: 743-8. Donze A, Smith JR, Bryowsky K. Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence. Neonatal Netw 2007; 26: 187-95. Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005; 10: 177-84. 1980; 215 1997; 62 2002; 30 1978; 93 1984; 247 1983; 53 1981; 68 1982; 101 2005; 20 2006; 19 1991; 118 1983; 11 2007; 28 2002; 161 2004; 93 2001 2001; 6 2004; 19 1986; 43 2006; 21 1994; 11 1983; 43 1996; 85 2005; 10 1982; 138 2000; 343 1983; 308 1977; 372 2007; 26 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 Chennavasin P (e_1_2_7_18_2) 1980; 215 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_12_2 e_1_2_7_26_2 e_1_2_7_27_2 Betkerur MV (e_1_2_7_6_2) 1981; 68 e_1_2_7_28_2 e_1_2_7_29_2 Katayama S (e_1_2_7_10_2) 1984; 247 Brion LP (e_1_2_7_11_2) 2001 e_1_2_7_25_2 e_1_2_7_24_2 e_1_2_7_30_2 e_1_2_7_23_2 e_1_2_7_31_2 e_1_2_7_22_2 e_1_2_7_21_2 Nies AS (e_1_2_7_19_2) 1983; 11 e_1_2_7_20_2 Vargas‐Origel A (e_1_2_7_13_2) 1986; 43 |
| References_xml | – volume: 11 start-page: 220 year: 1994 end-page: 2 article-title: Predicting oliguria following indomethacin for treatment of patent ductus arteriosus publication-title: Am J Perinatol – volume: 215 start-page: 77 year: 1980 end-page: 81 article-title: Pharmacokinetic‐dynamic analysis of the indomethacin–furosemide interaction in man publication-title: J Pharmacol Exp Ther – volume: 308 start-page: 743 year: 1983 end-page: 8 article-title: Furosemide promotes patent ductus arteriosus in premature infants with the respiratory‐distress syndrome publication-title: N Engl J Med – volume: 10 start-page: 177 year: 2005 end-page: 84 article-title: The pharmacologic closure of the patent ductus arteriosus publication-title: Semin Fetal Neonatal Med – volume: 20 start-page: 1552 year: 2005 end-page: 6 article-title: Urinary ET‐1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus publication-title: Pediatr Nephrol – volume: 19 start-page: 793 year: 2006 end-page: 9 article-title: Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates—is postnatal age at start of treatment important? publication-title: J Matern Fetal Neonatal Med – volume: 85 start-page: 1393 year: 1996 end-page: 9 article-title: Pharmacokinetics and renal function in preterm infants publication-title: Acta Paediatr – volume: 93 start-page: 233 year: 2004 end-page: 40 article-title: High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus publication-title: Acta Paediatr – volume: 11 start-page: 529 year: 1983 end-page: 33 article-title: Indomethacin–furosemide interaction: the importance of renal blood flow publication-title: Adv Prostaglandin Thromboxane Leukot Res – volume: 372 start-page: 215 year: 1977 end-page: 20 article-title: The effect of indomethacin on kidney function: indomethacin and furosemide antagonism publication-title: Pflugers Arch – volume: 21 start-page: 1690 year: 2006 end-page: 7 article-title: Indomethacin decreases furosemide‐induced natriuresis and diuresis on the neonatal kidney publication-title: Pediatr Nephrol – volume: 43 start-page: 152 year: 1983 end-page: 7 article-title: Effects of continuous positive airway pressure on renal function in prematures publication-title: Biol Neonate – volume: 68 start-page: 99 year: 1981 end-page: 102 article-title: Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus publication-title: Pediatrics – volume: 19 start-page: 490 year: 2004 end-page: 3 article-title: Indomethacin and renal impairment in neonates publication-title: Pediatr Nephrol – volume: 161 start-page: 202 year: 2002 end-page: 7 article-title: Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial publication-title: Eur J Pediatr – volume: 26 start-page: 187 year: 2007 end-page: 95 article-title: Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence publication-title: Neonatal Netw – volume: 62 start-page: 181 year: 1997 end-page: 6 article-title: Furosemide does not prevent indomethacin‐induced renal side effects in preterm infants publication-title: Clin Pharmacol Ther – volume: 43 start-page: 482 year: 1986 end-page: 8 article-title: Indomethacin and furosemide in closure of ductus arteriosus publication-title: Bol Med Hosp Infant Mex – volume: 247 start-page: F555 year: 1984 end-page: 61 article-title: Mechanism of furosemide‐induced natriuresis by direct stimulation of renal prostaglandin E2 publication-title: Am J Physiol – start-page: CD001148 year: 2001 article-title: Furosemide for symptomatic patent ductus arteriosus in indomethacin‐treated infants publication-title: Cochrane Database Syst Rev – volume: 138 start-page: 151 year: 1982 end-page: 3 article-title: Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants publication-title: Eur J Pediatr – volume: 20 start-page: 534 year: 2005 end-page: 9 article-title: Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus publication-title: Fetal Diagn Ther – volume: 118 start-page: 621 year: 1991 end-page: 6 article-title: Indomethacin‐induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging publication-title: J Pediatr – volume: 93 start-page: 512 year: 1978 end-page: 15 article-title: Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low‐birth‐weight infants publication-title: J Pediatr – volume: 343 start-page: 674 year: 2000 end-page: 81 article-title: A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus publication-title: N Engl J Med – volume: 30 start-page: 343 year: 2002 end-page: 8 article-title: Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus publication-title: Crit Care Med – volume: 53 start-page: 630 year: 1983 end-page: 5 article-title: Factors modifying the early nondiuretic vascular effects of furosemide in man publication-title: Circ Res – volume: 6 start-page: 63 year: 2001 end-page: 73 article-title: The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials publication-title: Semin Neonatol – volume: 28 start-page: 193 year: 2007 end-page: 200 article-title: Indomethacin use for the management of patent ductus arteriosus in preterms: a web‐based survey of practice attitudes among neonatal fellowship program directors in the United States publication-title: Pediatr Cardiol – volume: 101 start-page: 433 year: 1982 end-page: 7 article-title: Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus publication-title: J Pediatr – volume: 247 start-page: F555 year: 1984 ident: e_1_2_7_10_2 article-title: Mechanism of furosemide‐induced natriuresis by direct stimulation of renal prostaglandin E2 publication-title: Am J Physiol contributor: fullname: Katayama S – volume: 43 start-page: 482 year: 1986 ident: e_1_2_7_13_2 article-title: Indomethacin and furosemide in closure of ductus arteriosus publication-title: Bol Med Hosp Infant Mex contributor: fullname: Vargas‐Origel A – ident: e_1_2_7_4_2 doi: 10.1891/0730-0832.26.3.187 – ident: e_1_2_7_15_2 doi: 10.1007/BF00441143 – volume: 215 start-page: 77 year: 1980 ident: e_1_2_7_18_2 article-title: Pharmacokinetic‐dynamic analysis of the indomethacin–furosemide interaction in man publication-title: J Pharmacol Exp Ther contributor: fullname: Chennavasin P – start-page: CD001148 year: 2001 ident: e_1_2_7_11_2 article-title: Furosemide for symptomatic patent ductus arteriosus in indomethacin‐treated infants publication-title: Cochrane Database Syst Rev contributor: fullname: Brion LP – ident: e_1_2_7_21_2 doi: 10.1080/14767050600922610 – ident: e_1_2_7_14_2 doi: 10.1016/S0009-9236(97)90066-7 – ident: e_1_2_7_9_2 doi: 10.1016/S0022-3476(05)83391-8 – ident: e_1_2_7_22_2 doi: 10.1111/j.1651-2227.2004.tb00712.x – ident: e_1_2_7_31_2 doi: 10.1016/j.siny.2004.10.003 – ident: e_1_2_7_24_2 doi: 10.1161/01.RES.53.5.630 – ident: e_1_2_7_28_2 doi: 10.1056/NEJM198303313081303 – volume: 68 start-page: 99 year: 1981 ident: e_1_2_7_6_2 article-title: Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus publication-title: Pediatrics doi: 10.1542/peds.68.1.99 contributor: fullname: Betkerur MV – ident: e_1_2_7_27_2 doi: 10.1007/s00467-005-2022-6 – ident: e_1_2_7_23_2 doi: 10.1007/BF01063855 – ident: e_1_2_7_20_2 doi: 10.1007/s00467-006-0224-1 – ident: e_1_2_7_16_2 doi: 10.1097/00003246-200202000-00013 – ident: e_1_2_7_30_2 doi: 10.1056/NEJM200009073431001 – ident: e_1_2_7_7_2 doi: 10.1007/s00467-003-1402-z – ident: e_1_2_7_26_2 doi: 10.1159/000088046 – ident: e_1_2_7_2_2 doi: 10.1053/siny.2000.0036 – ident: e_1_2_7_17_2 doi: 10.1159/000241622 – ident: e_1_2_7_29_2 doi: 10.1007/s00431-002-0915-y – volume: 11 start-page: 529 year: 1983 ident: e_1_2_7_19_2 article-title: Indomethacin–furosemide interaction: the importance of renal blood flow publication-title: Adv Prostaglandin Thromboxane Leukot Res contributor: fullname: Nies AS – ident: e_1_2_7_8_2 doi: 10.1016/S0022-3476(78)81182-2 – ident: e_1_2_7_25_2 doi: 10.1111/j.1651-2227.1996.tb13942.x – ident: e_1_2_7_3_2 doi: 10.1007/s00246-006-0093-1 – ident: e_1_2_7_5_2 doi: 10.1055/s-2008-1040750 – ident: e_1_2_7_12_2 doi: 10.1016/S0022-3476(82)80079-6 |
| SSID | ssj0023946 ssj0004374 |
| Score | 2.0673172 |
| Snippet | Objective: To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 × 0.2 mg/kg at 12‐h... To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 x 0.2 mg/kg at 12-h intervals) for... Abstract Objective: To evaluate the effect of furosemide on renal function and water balance in preterm infants treated with indomethacin (3 × 0.2 mg/kg at... |
| SourceID | crossref pubmed pascalfrancis wiley istex |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 797 |
| SubjectTerms | Biological and medical sciences Cohort Studies Creatinine - blood Cyclooxygenase Inhibitors - adverse effects Diuretics - therapeutic use Ductus Arteriosus, Patent - drug therapy Female Furosemide Furosemide - therapeutic use General aspects Humans Indomethacin Indomethacin - adverse effects Infant, Newborn Infant, Premature Kidney Diseases - chemically induced Kidney Diseases - prevention & control Kidney Function Tests Male Medical sciences Multivariate Analysis Patent ductus arteriosus Renal function Retrospective Studies Sodium - blood Treatment Outcome Urine |
| Title | Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus |
| URI | https://api.istex.fr/ark:/67375/WNG-9GP9NHMN-1/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1651-2227.2009.01224.x https://www.ncbi.nlm.nih.gov/pubmed/19187396 |
| Volume | 98 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pa9swFH6MFkYvW7utq9u16DB2c4gtWbGOoTQNhYYyWtabkCwJQqhT6gTK_vq-J7tpUnYYpRcjbOQf70l637M-fQL4ab0zAcNM2jeCluR4lVph8GCrkHkrfV5Ftc-JHN-Ii9vituM_0VqYVh9i9cONekYcr6mDG9tsdnJZZCmt5exkJ2mSqEd4knT1CB_9flGSEpxgTpeIcdUu4Cn7HBOxgm8yfP55142wtU0eeCQapWnQkqHdAmMthq3j3BioRp9h9vyJLT9l1lsubK_6-0r98X1ssAufOjzLhm0D3IMPvv4CHy-7GfuvcD0ivUx_N3WeTWtG9EaMBVgMRMBhkefuHaPfwXjSzWlHa4NVGYJpdo_X6gUjSdplwyL7dDpvls03uBmdXZ-O024nh7RCOCZSbp20ufdK2KCEMyo3fekNF_jSQcnMVAOBOE0NaOLYGVsKxyV6JivKSmQ4KO3DVj2v_QEw7nPrQ865tQHBjzBO2cBLGqsqi-lXAtmzo_R9K9ih1xIdNJcmc9H2m0pHc-nHBH5Fj64qmIcZEd4Ghf4zOdfq_EpNxpcTnSVwsuHyVQXSe8dcRSTwvW0DL89WWTngSiYgoyf_-6X08GpIpcO3VjyCnXbqi9iZP2Br8bD0x4igFvYk9o0n8mAJ9A |
| link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwED6hTQJexm8WBsMPiLdUTey48WPF6Aqs0YQ6sTfLjm2pGkuntZWm_fXcOVnXIh4Q4qWKWrlN73K-7-zP3wF8sN6ZgGkm7RtBR3K8Sq0w-GLrkHkrfV5Htc9Kjs_E1_PivGsHRGdhWn2I9YIbRUacrynAaUF6O8plkaV0mLPTnaRdoh4Cyl2M_oKi9Oj7vZaU4AR0ulKMq_YIT9nnWIoVfJvj88ev3Upcu-SDGyJSmgXaMrRNMDay2CbSjalq9AR-3v3JlqFy0Vstba--_U3_8T9Z4SnsdZCWDdtn8Bk88M1zeDjpNu1fwHREkpn-cuY8mzWMGI6YDvAyEAeHRaq7d4xWhPFNN6em1gaHMsTT7Ao_a5aMVGlXCxYJqLP5YrV4CWejz9NP47Rr5pDWiMhEyq2TNvdeCRuUcEblpi-94QJvOiiZmXogEKqpAe0dO2NL4bhE12RFWYsM56VXsNPMG78PjPvc-pBzbm1A_COMUzbwkqar2mIFlkB25yl91Wp26I1aB82lyVzUgVPpaC59k8DH6NL1AHN9QZy3QaF_VMdaHZ-qajypdJbA4ZbP1wNI8h3LFZHA6_YhuP9tlZUDrmQCMrryr29KD0-HdPXmXwe-h0fj6eREn3ypvh3A43YnjMiab2Fneb3y7xBQLe1hDJRfsy8OFA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9swFD6MFspetnVXb2unh7E3h9iSFesxrEuzS00YLeubkCwJQqgTmgTKfv3Okd00GX0oYy9G2MiXcySd71ifPgF8tN6ZgGEm7RtBS3K8Sq0weLB1yLyVPq-j2mclxxfi22Vx2fGfaC1Mqw-x-eFGPSOO19TBFy7sdnJZZCmt5exkJ2mSqId4cl9InlMidvLzTkpKcMI5XSbGVbuCp-xzzMQKvkvxufe2O3Frn1xwQzxKs0RThnYPjK0gtg10Y6QaPYXZ7Te2BJVZb72yvfr3X_KP_8cIz-BJB2jZsG2Bh_DIN8_h4Kybsn8B5yMSzPRXU-fZtGHEb8RggMVADBwWie7eMfofjCfdnLa0NliVIZpmC7zWrBhp0q6XLNJPp_PlevkSLkZfzj-P024rh7RGPCZSbp20ufdK2KCEMyo3fekNF_jSQcnM1AOBQE0NaObYGVsKxyV6JivKWmQ4Kr2CvWbe-DfAuM-tDznn1gZEP8I4ZQMvabCqLeZfCWS3jtKLVrFDb2U6aC5N5qL9N5WO5tI3CXyKHt1UMNczYrwNCv2rOtXqdKKq8VmlswSOd1y-qUCC75isiARet23g7tkqKwdcyQRk9OSDX0oPJ0Mqvf3Xih_gYHIy0j--Vt_fweN2GoyYmu9hb3W99keIplb2OHaTP2oNDMM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Furosemide+in+preterm+infants+treated+with+indomethacin+for+patent+ductus+arteriosus&rft.jtitle=Acta+p%C3%A6diatrica+%28Oslo%29&rft.au=ANDRIESSEN%2C+Peter&rft.au=STRUIS%2C+Nicole+C&rft.au=NIEMARKT%2C+Hendrik&rft.au=SIDARTO+BAMBANG+OETOMO&rft.date=2009-05-01&rft.pub=Blackwell&rft.issn=0803-5253&rft.eissn=1651-2227&rft.volume=98&rft.issue=5&rft.spage=797&rft.epage=803&rft_id=info:doi/10.1111%2Fj.1651-2227.2009.01224.x&rft.externalDBID=n%2Fa&rft.externalDocID=21458824 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0803-5253&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0803-5253&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0803-5253&client=summon |